No AccessJournal of UrologyClinical Urology: Letters to the Editor1 Nov 1998RE: OSTEOPOROSIS AFTER ORCHIECTOMY FOR PROSTATE CANCER John Wei, Katherine Gravlin, and Kathleen A. Cooney John WeiJohn Wei More articles by this author , Katherine GravlinKatherine Gravlin More articles by this author , and Kathleen A. CooneyKathleen A. Cooney More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)62422-4AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: OSTEOPOROSIS AFTER ORCHIECTOMY FOR PROSTATE CANCER." The Journal of Urology, 160(5), p. 1809 References 1 : Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens. Calcif. Tissue Int.1995; 57: 97. Google Scholar 2 : Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate cancer. Cancer1997; 79: 545. Crossref, Medline, Google Scholar 3 : Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. New Engl. J. Med.1995; 333: 1437. Google Scholar Section of Urology and Department of Internal Medicine; The University of Michigan Medical School; Ann Arbor Veterans Administration Hospital; 1500 East Medical Center Dr.; Ann Arbor, Michigan 48109-0330© 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited bySCHERR D and PITTS W (2018) The Nonsteroidal Effects of Diethylstilbestrol: The Rationale for Androgen Deprivation Therapy Without Estrogen Deprivation in the Treatment of Prostate CancerJournal of Urology, VOL. 170, NO. 5, (1703-1708), Online publication date: 1-Nov-2003.SCHERR D, PITTS W and VAUGHAN E (2018) DIETHYLSTILBESTEROL REVISITED: ANDROGEN DEPRIVATION, OSTEOPOROSIS AND PROSTATE CANCERJournal of Urology, VOL. 167, NO. 2 Part 1, (535-538), Online publication date: 1-Feb-2002.Walther M and Pitts W (2018) RE: MEDICAL VERSUS SURGICAL ANDROGEN SUPPRESSION THERAPY FOR PROSTATE CANCER: A 10-YEAR LONGITUDINAL COST STUDYJournal of Urology, VOL. 166, NO. 2, (632-632), Online publication date: 1-Aug-2001.Pavlovich C and Pitts W (2018) RE: OSTEOPOROSIS AFTER ORCHIECTOMY FOR PROSTATE CANCERJournal of Urology, VOL. 162, NO. 4, (1392-1392), Online publication date: 1-Oct-1999. Volume 160Issue 5November 1998Page: 1809 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information John Wei More articles by this author Katherine Gravlin More articles by this author Kathleen A. Cooney More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Wei et al. (1998) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: